Collaboration for rare disease drug discovery research [v1; ref status: indexed, http://f1000r.es/4l6]

Rare disease research has reached a tipping point, with the confluence of scientific and technologic developments that if appropriately harnessed, could lead to key breakthroughs and treatments for this set of devastating disorders. Industry-wide trends have revealed that the traditional drug discov...

Full description

Bibliographic Details
Main Authors: Nadia K. Litterman, Michele Rhee, David C. Swinney, Sean Ekins
Format: Article
Language:English
Published: F1000 Research Ltd 2014-10-01
Series:F1000Research
Subjects:
Online Access:http://f1000research.com/articles/3-261/v1